SpineX closes recruitment for trial evaluating Scone SCS technology in neurogenic bladder
SpineX has closed recruitment for the CONTINENCE clinical trial of its proprietary Scone device. The study began back in May 2022 and is evaluating...
Orthobond secures US FDA nod for antibacterial surface treatment applied to a spinal device
Orthobond Corporation has announced that the US Food and Drug Administration (FDA) recently granted its de novo marketing request for the use of Ostaguard—its...
Medcura closes US$22.4 million in financing to boost surgical haemostasis portfolio
Medcura has announced that it has closed a private placement with aggregate gross proceeds of US$22.4 million in convertible debt. The company intends to use the...
HIG Capital acquires ZimVie’s Spine business, now rebranded as Highridge Medical
HIG Capital has announced that one of its affiliates has completed the acquisition of the Spine division of ZimVie, with the acquired business set...
